Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Escalation of Roflumilast in COPD
NCT02018432Phase 4Unknown
- Sponsor
- Asan Medical Center
- Start
- Dec 2013
- Primary completion
- Dec 2015
- Countries
- 1
01
Overview
A Phase 4 trial of roflumilast in chronic obstructive pulmonary disease (COPD), sponsored by Asan Medical Center. Status: unknown.
02
Drugs
roflumilast
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02018432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02018432.